10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year.
Umedic Group Bhd does not have enough data to calculate 10-Year ROIIC %.
Umedic Group Bhd 10-Year ROIIC % Historical Data
The historical data trend for Umedic Group Bhd's 10-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Umedic Group Bhd's 10-Year ROIIC %
For the Medical Devices subindustry, Umedic Group Bhd's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Umedic Group Bhd's 10-Year ROIIC % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Umedic Group Bhd's 10-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Umedic Group Bhd's 10-Year ROIIC % falls into.
Umedic Group Bhd's 10-Year ROIIC % for the quarter that ended in Jul. 2024 is calculated as:
10-Year ROIIC %
=
10-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
10-Year Incremental Invested Capital**
=
( 8.2677555 (Jul. 2024) - (Jul. 2014) )
/
( 65.02 (Jul. 2024) - (Jul. 2014) )
=
/
=
N/A%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Umedic Group Bhd (XKLS:0256) 10-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Umedic Group Bhd 10-Year ROIIC % Related Terms
Thank you for viewing the detailed overview of Umedic Group Bhd's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
Umedic Group Bhd is principally involved in the marketing and distribution of various branded medical devices and consumables as well as the provision of after-sales service for all products. The company is also involved in developing, manufacturing, and marketing of medical consumables. It has two reportable segments: marketing and distribution, which includes marketing and distribution of medical devices and the provision of after-sales service; the manufacturing segment includes developing, manufacturing, and marketing of medical devices. The company generates the majority of its revenue from the marketing and distribution segment. The company has customers in Asia Pacific, Americas, Europe, Middle East, Africa, and Oceania geographically.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKLS:0256 has been successfully added to your 